SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Continucare (CNU) depr. PSYCLE sm buy again ?

 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: Stitch who wrote (11)3/28/1998 4:19:00 PM
From: Worswick   of 17
 
With only one analyst and several of the larger New York managers buying the stock... I suspect that the herd is not far behind.

An interesting post on Yahoo from a physical therapy person saying that what CNU has bought is the highest quality but she(he)worries about "rationalizing" all these purchases into a cohesive company. That, however, is what the company is all about. It is organizing from the ground up a whole sector, then be a sub-licensee of the larger HMO's.

My best to you,

NB Oddly, the stock is still trading at just fractions over what Soros paid last year, and it is "underwater" for many of the New York financial professionals and what they paid last year. So. These people saw value at $6-8 per share.

Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext